- Home
- FORR vs MBOT Comparison
FORR vs MBOT Comparison
Compare FORR & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FORR | MBOT |
|---|---|---|
| Founded | 1983 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.9M | 134.3M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | FORR | MBOT |
|---|---|---|
| Price | $8.32 | $2.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.75 |
| AVG Volume (30 Days) | 97.7K | ★ 1.3M |
| Earning Date | 02-10-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $403,871,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,119.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.60 | $1.25 |
| 52 Week High | $15.80 | $4.67 |
Technical Indicators
Market Signals| Indicator | FORR | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 67.15 | 49.99 |
| Support Level | $8.09 | $2.06 |
| Resistance Level | $8.44 | $2.18 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 90.17 | 77.78 |
Price Performance
Historical ComparisonAbout FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.